Equities

Meihua International Medical Technologies Co Ltd

MHUA:NMQ

Meihua International Medical Technologies Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.02
  • Today's Change-0.015 / -1.46%
  • Shares traded78.97k
  • 1 Year change-52.79%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 20:57 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Meihua International Medical Technologies Co Ltd had revenues fall -6.05% from 103.35m to 97.10m, though the company grew net income 86.22% from 6.24m to 11.63m.
Gross margin34.19%
Net profit margin11.94%
Operating margin15.11%
Return on assets6.91%
Return on equity8.17%
Return on investment8.13%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Meihua International Medical Technologies Co Ltd fell by 9.81m. However, the company earned 2.28m from its operations for a Cash Flow Margin of 2.34%. In addition the company generated 706.13k cash from financing while 12.46m was spent on investing.
Cash flow per share0.5038
Price/Cash flow per share2.17
Book value per share6.11
Tangible book value per share5.95
More ▼

Balance sheet in USDView more

Meihua International Medical Technologies Co Ltd uses little debt in its capital structure as supported by a debt to capital ratio of 4.75%.
Current ratio5.27
Quick ratio5.21
Total debt/total equity0.05
Total debt/total capital0.0475
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 82.10%. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
EPS growth(5 years)-8.90
EPS (TTM) vs
TTM 1 year ago
82.10
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.